1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism

Thomas K. Barthel, Douglas R. Mathern, G. Kerr Whitfield, Carol A. Haussler, H. Andrew Hopper IV, Jui Cheng Hsieh, Stephanie A. Slater, Grace Hsieh, Magdalena Kaczmarska, Peter Jurutka, Olga I. Kolek, Fayez K. Ghishan, Mark R. Haussler

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

1,25-Dihydroxyvitamin D3 (1,25D) is known primarily as a regulator of calcium, but 1,25D also promotes phosphate absorption from intestine, reabsorption from kidney, and bone mineral resorption. FGF23 is a newly discovered phosphaturic hormone that, like PTH, lowers serum phosphate by inhibiting renal reabsorption via Npt2a. We show that 1,25D strongly upregulates FGF23 in bone. FGF23 then represses 1α-OHase activity in kidney, thus preventing spiraling induction of FGF23 by 1,25D. We also report that LRP5, Runx2, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic, are transcriptionally regulated by 1,25D. This coordinated regulation together with that of FGF23 and PTH allows 1,25D to play a central role in maintaining calcium and phosphate homeostasis and bone metabolism. In the cases of LRP5, Runx2, TRPV6, and Npt2c we show that transcriptional regulation results at least in part from direct binding of VDR near the relevant gene promoter. Finally, because 1,25D induces FGF23, and FGF23 in turn represses 1,25D synthesis, a reciprocal relationship is established with FGF23 indirectly curtailing 1,25D-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate. This newly revealed FGF23/1,25D/Pi axis is comparable in significance to phosphate and bone metabolism as the PTH/1,25D/Ca axis is to calcium homeostasis.

Original languageEnglish (US)
Pages (from-to)381-388
Number of pages8
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume103
Issue number3-5
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Calcitriol
Metabolism
Minerals
Bone
Genes
Bone and Bones
Phosphates
Homeostasis
calcium phosphate
Calcium
Kidney
Intestinal Absorption
Bone Resorption
Intestines
Up-Regulation
Hormones

Keywords

  • Bone mineral metabolism
  • Calcium metabolism
  • Fibroblast growth factor-23
  • LRP5
  • Npt2c
  • PHEX
  • Phosphate metabolism
  • RANKL
  • Runx2
  • TRPV6
  • Vitamin D receptor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. / Barthel, Thomas K.; Mathern, Douglas R.; Whitfield, G. Kerr; Haussler, Carol A.; Hopper IV, H. Andrew; Hsieh, Jui Cheng; Slater, Stephanie A.; Hsieh, Grace; Kaczmarska, Magdalena; Jurutka, Peter; Kolek, Olga I.; Ghishan, Fayez K.; Haussler, Mark R.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 103, No. 3-5, 03.2007, p. 381-388.

Research output: Contribution to journalArticle

Barthel, Thomas K. ; Mathern, Douglas R. ; Whitfield, G. Kerr ; Haussler, Carol A. ; Hopper IV, H. Andrew ; Hsieh, Jui Cheng ; Slater, Stephanie A. ; Hsieh, Grace ; Kaczmarska, Magdalena ; Jurutka, Peter ; Kolek, Olga I. ; Ghishan, Fayez K. ; Haussler, Mark R. / 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. In: Journal of Steroid Biochemistry and Molecular Biology. 2007 ; Vol. 103, No. 3-5. pp. 381-388.
@article{66cf2f2a203c4e90a5ea5b00fe0379b2,
title = "1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism",
abstract = "1,25-Dihydroxyvitamin D3 (1,25D) is known primarily as a regulator of calcium, but 1,25D also promotes phosphate absorption from intestine, reabsorption from kidney, and bone mineral resorption. FGF23 is a newly discovered phosphaturic hormone that, like PTH, lowers serum phosphate by inhibiting renal reabsorption via Npt2a. We show that 1,25D strongly upregulates FGF23 in bone. FGF23 then represses 1α-OHase activity in kidney, thus preventing spiraling induction of FGF23 by 1,25D. We also report that LRP5, Runx2, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic, are transcriptionally regulated by 1,25D. This coordinated regulation together with that of FGF23 and PTH allows 1,25D to play a central role in maintaining calcium and phosphate homeostasis and bone metabolism. In the cases of LRP5, Runx2, TRPV6, and Npt2c we show that transcriptional regulation results at least in part from direct binding of VDR near the relevant gene promoter. Finally, because 1,25D induces FGF23, and FGF23 in turn represses 1,25D synthesis, a reciprocal relationship is established with FGF23 indirectly curtailing 1,25D-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate. This newly revealed FGF23/1,25D/Pi axis is comparable in significance to phosphate and bone metabolism as the PTH/1,25D/Ca axis is to calcium homeostasis.",
keywords = "Bone mineral metabolism, Calcium metabolism, Fibroblast growth factor-23, LRP5, Npt2c, PHEX, Phosphate metabolism, RANKL, Runx2, TRPV6, Vitamin D receptor",
author = "Barthel, {Thomas K.} and Mathern, {Douglas R.} and Whitfield, {G. Kerr} and Haussler, {Carol A.} and {Hopper IV}, {H. Andrew} and Hsieh, {Jui Cheng} and Slater, {Stephanie A.} and Grace Hsieh and Magdalena Kaczmarska and Peter Jurutka and Kolek, {Olga I.} and Ghishan, {Fayez K.} and Haussler, {Mark R.}",
year = "2007",
month = "3",
doi = "10.1016/j.jsbmb.2006.12.054",
language = "English (US)",
volume = "103",
pages = "381--388",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "3-5",

}

TY - JOUR

T1 - 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism

AU - Barthel, Thomas K.

AU - Mathern, Douglas R.

AU - Whitfield, G. Kerr

AU - Haussler, Carol A.

AU - Hopper IV, H. Andrew

AU - Hsieh, Jui Cheng

AU - Slater, Stephanie A.

AU - Hsieh, Grace

AU - Kaczmarska, Magdalena

AU - Jurutka, Peter

AU - Kolek, Olga I.

AU - Ghishan, Fayez K.

AU - Haussler, Mark R.

PY - 2007/3

Y1 - 2007/3

N2 - 1,25-Dihydroxyvitamin D3 (1,25D) is known primarily as a regulator of calcium, but 1,25D also promotes phosphate absorption from intestine, reabsorption from kidney, and bone mineral resorption. FGF23 is a newly discovered phosphaturic hormone that, like PTH, lowers serum phosphate by inhibiting renal reabsorption via Npt2a. We show that 1,25D strongly upregulates FGF23 in bone. FGF23 then represses 1α-OHase activity in kidney, thus preventing spiraling induction of FGF23 by 1,25D. We also report that LRP5, Runx2, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic, are transcriptionally regulated by 1,25D. This coordinated regulation together with that of FGF23 and PTH allows 1,25D to play a central role in maintaining calcium and phosphate homeostasis and bone metabolism. In the cases of LRP5, Runx2, TRPV6, and Npt2c we show that transcriptional regulation results at least in part from direct binding of VDR near the relevant gene promoter. Finally, because 1,25D induces FGF23, and FGF23 in turn represses 1,25D synthesis, a reciprocal relationship is established with FGF23 indirectly curtailing 1,25D-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate. This newly revealed FGF23/1,25D/Pi axis is comparable in significance to phosphate and bone metabolism as the PTH/1,25D/Ca axis is to calcium homeostasis.

AB - 1,25-Dihydroxyvitamin D3 (1,25D) is known primarily as a regulator of calcium, but 1,25D also promotes phosphate absorption from intestine, reabsorption from kidney, and bone mineral resorption. FGF23 is a newly discovered phosphaturic hormone that, like PTH, lowers serum phosphate by inhibiting renal reabsorption via Npt2a. We show that 1,25D strongly upregulates FGF23 in bone. FGF23 then represses 1α-OHase activity in kidney, thus preventing spiraling induction of FGF23 by 1,25D. We also report that LRP5, Runx2, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic, are transcriptionally regulated by 1,25D. This coordinated regulation together with that of FGF23 and PTH allows 1,25D to play a central role in maintaining calcium and phosphate homeostasis and bone metabolism. In the cases of LRP5, Runx2, TRPV6, and Npt2c we show that transcriptional regulation results at least in part from direct binding of VDR near the relevant gene promoter. Finally, because 1,25D induces FGF23, and FGF23 in turn represses 1,25D synthesis, a reciprocal relationship is established with FGF23 indirectly curtailing 1,25D-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate. This newly revealed FGF23/1,25D/Pi axis is comparable in significance to phosphate and bone metabolism as the PTH/1,25D/Ca axis is to calcium homeostasis.

KW - Bone mineral metabolism

KW - Calcium metabolism

KW - Fibroblast growth factor-23

KW - LRP5

KW - Npt2c

KW - PHEX

KW - Phosphate metabolism

KW - RANKL

KW - Runx2

KW - TRPV6

KW - Vitamin D receptor

UR - http://www.scopus.com/inward/record.url?scp=33947192418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947192418&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2006.12.054

DO - 10.1016/j.jsbmb.2006.12.054

M3 - Article

VL - 103

SP - 381

EP - 388

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 3-5

ER -